{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:24:29Z","timestamp":1786926269950,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"DOI":"10.1038\/s41387-026-00440-y","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:56:25Z","timestamp":1781092585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insulin resistance drives GGT elevation in MASLD with diabetes: evidence from clinical cohorts, mendelian randomization and functional genomics"],"prefix":"10.1038","volume":"16","author":[{"given":"Ayan","family":"Mandal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debopriyo","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandana","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1564-0284","authenticated-orcid":false,"given":"Analabha","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1194-861X","authenticated-orcid":false,"given":"Priyadarshi","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"440_CR1","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J, Sanyal A, Neuschwander-Tetri B, Tiribelli C, et al. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158:1999\u20132014.e1. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.312.","journal-title":"Gastroenterology"},{"key":"440_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384. https:\/\/doi.org\/10.1002\/hep.28431.","journal-title":"Hepatology"},{"key":"440_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cld.2015.10.011","volume":"20","author":"DE Kleiner","year":"2016","unstructured":"Kleiner DE, Makhlouf HR. Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children. Clin Liver Dis. 2016;20:293\u2013312. https:\/\/doi.org\/10.1016\/j.cld.2015.10.011.","journal-title":"Clin Liver Dis"},{"key":"440_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","volume":"19","author":"JV Lazarus","year":"2022","unstructured":"Lazarus JV, Mark HE, Anstee QM, Arab JP, Batterham RL, Castera L, et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol. 2022;19:60\u201378. https:\/\/doi.org\/10.1038\/s41575-021-00523-4.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"440_CR5","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.jceh.2021.11.010","volume":"12","author":"Shalimar","year":"2022","unstructured":"Shalimar, Elhence A, Bansal B, Gupta H, Anand A, Singh TP, et al. Prevalence of non-alcoholic fatty liver disease in india: a systematic review and meta-analysis. J Clin Exp Hepatol. 2022;12:818\u201329. https:\/\/doi.org\/10.1016\/j.jceh.2021.11.010.","journal-title":"J Clin Exp Hepatol"},{"key":"440_CR6","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.aohep.2023.101133","volume":"29","author":"ME Rinella","year":"2024","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol. 2024;29:101133 https:\/\/doi.org\/10.1016\/j.aohep.2023.101133.","journal-title":"Ann Hepatol"},{"key":"440_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.endinu.2017.12.011","volume":"65","author":"R Aller de la Fuente","year":"2018","unstructured":"Aller de la Fuente R, Mora Cuadrado N, Tafur C, L\u00f3pez G\u00f3mez JJ, G\u00f3mez de la Cuesta S, Garc\u00eda S\u00e1nchez MC, et al. Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes. Endocrinol Diab Nutr. 2018;65:354\u201360. https:\/\/doi.org\/10.1016\/j.endinu.2017.12.011.","journal-title":"Endocrinol Diab Nutr"},{"key":"440_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/liv.15730","volume":"44","author":"R Forlano","year":"2024","unstructured":"Forlano R, Stanic T, Jayawardana S, Mullish BH, Yee M, Mossialos E, et al. A prospective study on the prevalence of MASLD in people with type-2 diabetes in the community. Cost effectiveness of screening strategies. Liver Int. 2024;44:61\u201371. https:\/\/doi.org\/10.1111\/liv.15730.","journal-title":"Liver Int"},{"key":"440_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jhep.2022.11.010","volume":"78","author":"V Ajmera","year":"2023","unstructured":"Ajmera V, Cepin S, Tesfai K, Hofflich H, Cadman K, Lopez S, et al. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes. J Hepatol. 2023;78:471\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2022.11.010.","journal-title":"J Hepatol"},{"key":"440_CR10","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1136\/gutjnl-2023-330110","volume":"72","author":"E En Li Cho","year":"2023","unstructured":"En Li Cho E, Ang CZ, Quek J, Fu CE, Lim LKE, Heng ZEQ, et al. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis. Gut. 2023;72:2138\u20132148. https:\/\/doi.org\/10.1136\/gutjnl-2023-330110.","journal-title":"Gut"},{"key":"440_CR11","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/ajg.2014.132","volume":"109","author":"G Zoppini","year":"2014","unstructured":"Zoppini G, Fedeli U, Gennaro N, Saugo M, Targher G, Bonora E. Mortality from chronic liver diseases in diabetes. Am J Gastroenterol. 2014;109:1020\u20135. https:\/\/doi.org\/10.1038\/ajg.2014.132.","journal-title":"Am J Gastroenterol"},{"key":"440_CR12","doi-asserted-by":"publisher","unstructured":"Khan RMM, Chua ZJY, Tan JC, Yang Y, Liao Z, Zhao Y From pre-diabetes to diabetes: Diagnosis, treatments and translational research. Medicina. 2019; 55. https:\/\/doi.org\/10.3390\/medicina55090546.","DOI":"10.3390\/medicina55090546"},{"key":"440_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2020.9320","volume":"20","author":"C Vesa","year":"2020","unstructured":"Vesa C, Behl T, Nemeth S, Bratu O, Diaconu C, Moleriu R, et al. Prediction of NAFLD occurrence in prediabetes patients. Exp Ther Med. 2020;20:1 https:\/\/doi.org\/10.3892\/etm.2020.9320.","journal-title":"Exp Ther Med"},{"key":"440_CR14","doi-asserted-by":"publisher","first-page":"7640","DOI":"10.4103\/jfmpc.jfmpc_856_22","volume":"11","author":"P Kumar","year":"2022","unstructured":"Kumar P, Rawat S, Kakar A, Sinha AK. Prevalence of non-alcoholic fatty liver disease among diabetes, prediabetes and healthy population. J Fam Med Prim Care. 2022;11:7640\u20133. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_856_22.","journal-title":"J Fam Med Prim Care"},{"key":"440_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","volume":"14","author":"H Tilg","year":"2017","unstructured":"Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017;14:32\u201342. https:\/\/doi.org\/10.1038\/nrgastro.2016.147.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"440_CR16","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1007\/s10620-015-3564-5","volume":"60","author":"M Li","year":"2015","unstructured":"Li M, Zhang S, Wu Y, Ye J, Cao X, Liu J, et al. Prevalence of Insulin Resistance in Subjects with Nonalcoholic Fatty Liver Disease and Its Predictors in a Chinese Population. Dig Dis Sci. 2015;60:2170\u20132176. https:\/\/doi.org\/10.1007\/s10620-015-3564-5.","journal-title":"Dig Dis Sci"},{"key":"440_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/4930355","volume":"2022","author":"X Cai","year":"2022","unstructured":"Cai X, Gao J, Hu J, Wen W, Zhu Q, Wang M, et al. Dose-response associations of metabolic score for insulin resistance index with nonalcoholic fatty liver disease among a nonobese Chinese population: retrospective evidence from a population-based cohort study. Dis Markers. 2022;2022:1\u201310. https:\/\/doi.org\/10.1155\/2022\/4930355.","journal-title":"Dis Markers"},{"key":"440_CR18","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.numecd.2023.05.018","volume":"33","author":"M Wang","year":"2023","unstructured":"Wang M, Zhao Y, He Y, Zhang L, Liu J, Zheng S, et al. The bidirectional relationship between NAFLD and type 2 diabetes: A prospective population-based cohort study. Nutr, Metab Cardiovasc Dis. 2023;33:1521\u20138. https:\/\/doi.org\/10.1016\/j.numecd.2023.05.018.","journal-title":"Nutr, Metab Cardiovasc Dis"},{"key":"440_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/liv.15099","volume":"42","author":"PN Brennan","year":"2022","unstructured":"Brennan PN, Dillon JF, Tapper EB. Gamma-Glutamyl Transferase (\u03b3-GT)-an old dog with new tricks?. Liver Int. 2022;42:9\u201315. https:\/\/doi.org\/10.1111\/liv.15099.","journal-title":"Liver Int"},{"key":"440_CR20","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.annepidem.2014.09.001","volume":"24","author":"SK Kunutsor","year":"2014","unstructured":"Kunutsor SK, Abbasi A, Adler AI. Gamma-glutamyl transferase and risk of type II diabetes: an updated systematic review and dose-response meta-analysis. Ann Epidemiol. 2014;24:809\u2013816. https:\/\/doi.org\/10.1016\/j.annepidem.2014.09.001.","journal-title":"Ann Epidemiol"},{"key":"440_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.diabres.2009.02.004","volume":"84","author":"JY Shin","year":"2009","unstructured":"Shin JY, Chang SJ, Shin YG, Seo KS, Chung CH. Elevated serum gamma-glutamyltransferase levels are independently associated with insulin resistance in non-diabetic subjects. Diab Res Clin Pr. 2009;84:152\u20137. https:\/\/doi.org\/10.1016\/j.diabres.2009.02.004.","journal-title":"Diab Res Clin Pr"},{"key":"440_CR22","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.atherosclerosis.2014.12.045","volume":"238","author":"SK Kunutsor","year":"2015","unstructured":"Kunutsor SK, Bakker SJL, Kootstra-Ros JE, Gansevoort RT, Dullaart RPF. Circulating gamma glutamyltransferase and prediction of cardiovascular disease. Atherosclerosis. 2015;238:356\u2013364. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.045.","journal-title":"Atherosclerosis"},{"key":"440_CR23","doi-asserted-by":"publisher","first-page":"145431","DOI":"10.1016\/j.gene.2021.145431","volume":"775","author":"A Chatterjee","year":"2021","unstructured":"Chatterjee A, Basu A, Das K, Chowdhury A, Basu P. Exome-wide scan identifies significant association of rs4788084 in IL27 promoter with increase in hepatic fat content among Indians. Gene. 2021;775:145431 https:\/\/doi.org\/10.1016\/j.gene.2021.145431.","journal-title":"Gene"},{"key":"440_CR24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u201319. https:\/\/doi.org\/10.1007\/BF00280883.","journal-title":"Diabetologia"},{"key":"440_CR25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","author":"A Berzigotti","year":"2021","unstructured":"Berzigotti A, Tsochatzis E, Boursier J, Castera L, Cazzagon N, Friedrich-Rust M, et al. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update. J Hepatol. 2021;75:659\u2013689. https:\/\/doi.org\/10.1016\/j.jhep.2021.05.025.","journal-title":"J Hepatol"},{"key":"440_CR26","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: Distinct clinicopathologic meanings. Hepatology. 2011;53:810\u2013820. https:\/\/doi.org\/10.1002\/hep.24127.","journal-title":"Hepatology"},{"key":"440_CR27","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u201321. https:\/\/doi.org\/10.1002\/hep.20701.","journal-title":"Hepatology"},{"key":"440_CR28","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: The STROBE-MR statement. J Am Med Assoc. 2021;326:1614 https:\/\/doi.org\/10.1001\/jama.2021.18236.","journal-title":"J Am Med Assoc"},{"key":"440_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57452-y","volume":"16","author":"M Sevilla-Gonz\u00e1lez","year":"2025","unstructured":"Sevilla-Gonz\u00e1lez M, Smith K, Wang N, Jensen AE, Litkowski EM, et al. Heterogeneous effects of genetic variants and traits associated with fasting insulin on cardiometabolic outcomes. Nat Commun. 2025;16:2569. https:\/\/doi.org\/10.1038\/s41467-025-57452-y.","journal-title":"Nat Commun"},{"key":"440_CR30","doi-asserted-by":"publisher","first-page":"BMI.S38440","DOI":"10.4137\/BMI.S38440","volume":"11","author":"SI Sherwani","year":"2016","unstructured":"Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomark Insights. 2016;11:BMI.S38440 https:\/\/doi.org\/10.4137\/BMI.S38440.","journal-title":"Biomark Insights"},{"key":"440_CR31","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41588-021-00852-9","volume":"53","author":"J Chen","year":"2021","unstructured":"Chen J, Spracklen CN, Marenne G, Varshney A, Corbin LJ, Luan J, et al. The trans-ancestral genomic architecture of glycemic traits. Nat Genet. 2021;53:840\u201360. https:\/\/doi.org\/10.1038\/s41588-021-00852-9.","journal-title":"Nat Genet"},{"key":"440_CR32","doi-asserted-by":"publisher","unstructured":"Liu Y, Basty N, Whitcher B, Bell JD, Sorokin EP, van Bruggen N, et al. Genetic architecture of 11 organ traits derived from abdominal MRI using deep learning. Elife. 2021; 10. https:\/\/doi.org\/10.7554\/eLife.65554.","DOI":"10.7554\/eLife.65554"},{"key":"440_CR33","doi-asserted-by":"publisher","first-page":"e0132244","DOI":"10.1371\/journal.pone.0132244","volume":"10","author":"G Saravia","year":"2015","unstructured":"Saravia G, Civeira F, Hurtado-Roca Y, Andres E, Leon M, Pocovi M, et al. Glycated hemoglobin, fasting insulin and the metabolic syndrome in males. Cross-sectional analyses of the Aragon Workers\u2019 health study baseline. PLoS One. 2015;10:e0132244 https:\/\/doi.org\/10.1371\/journal.pone.0132244.","journal-title":"PLoS One"},{"key":"440_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/DMSO.S577797","volume":"19","author":"O Albai","year":"2026","unstructured":"Albai O, Braha A, Timar R, Lazar S, Popescu S, Timar B. Markers of insulin resistance and their clinical implications in patients with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease. Diab, Metab Syndr Obes: Targets Ther. 2026;19:1\u201317. https:\/\/doi.org\/10.2147\/DMSO.S577797.","journal-title":"Diab, Metab Syndr Obes: Targets Ther"},{"key":"440_CR35","doi-asserted-by":"publisher","unstructured":"1000 Genomes Project Consortium; Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM et al. A global reference for human genetic variation. Nature. 2015; 526. https:\/\/doi.org\/10.1038\/nature15393.","DOI":"10.1038\/nature15393"},{"key":"440_CR36","doi-asserted-by":"publisher","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 2018; 50. https:\/\/doi.org\/10.1038\/s41588-018-0099-7.","DOI":"10.1038\/s41588-018-0099-7"},{"key":"440_CR37","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658\u201365. https:\/\/doi.org\/10.1002\/gepi.21758.","journal-title":"Genet Epidemiol"},{"key":"440_CR38","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512\u201325. https:\/\/doi.org\/10.1093\/ije\/dyv080.","journal-title":"Int J Epidemiol"},{"key":"440_CR39","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304\u201314. https:\/\/doi.org\/10.1002\/gepi.21965.","journal-title":"Genet Epidemiol"},{"key":"440_CR40","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1002\/sim.9133","volume":"40","author":"E Sanderson","year":"2021","unstructured":"Sanderson E, Spiller W, Bowden J. Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization. Stat Med. 2021;40:5434\u201352. https:\/\/doi.org\/10.1002\/sim.9133.","journal-title":"Stat Med"},{"key":"440_CR41","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1093\/ije\/dyx028","volume":"45","author":"FP Hartwig","year":"2016","unstructured":"Hartwig FP, Davies NM, Hemani G, Davey Smith G. Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique. Int J Epidemiol. 2016;45:1717\u201326. https:\/\/doi.org\/10.1093\/ije\/dyx028.","journal-title":"Int J Epidemiol"},{"key":"440_CR42","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/ije\/dyx034","volume":"46","author":"OO Yavorska","year":"2017","unstructured":"Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol. 2017;46:1734\u20139. https:\/\/doi.org\/10.1093\/ije\/dyx034.","journal-title":"Int J Epidemiol"},{"key":"440_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01261-5","volume":"8","author":"K Watanabe","year":"2017","unstructured":"Watanabe K, Taskesen E, Van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8:1826. https:\/\/doi.org\/10.1038\/s41467-017-01261-5.","journal-title":"Nat Commun"},{"key":"440_CR44","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","volume":"5","author":"R Ihaka","year":"1996","unstructured":"Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comput Graph Stat. 1996;5:299\u2013314. https:\/\/doi.org\/10.1080\/10618600.1996.10474713.","journal-title":"J Comput Graph Stat"},{"key":"440_CR45","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/gepi.22522","volume":"47","author":"N Mounier","year":"2023","unstructured":"Mounier N, Kutalik Z. Bias correction for inverse variance weighting Mendelian randomization. Genet Epidemiol. 2023;47:314\u201331. https:\/\/doi.org\/10.1002\/gepi.22522.","journal-title":"Genet Epidemiol"},{"key":"440_CR46","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.3390\/jcm12175597","volume":"12","author":"S Ciardullo","year":"2023","unstructured":"Ciardullo S, Vergani M, Perseghin G. Nonalcoholic fatty liver disease in patients with type 2 diabetes: screening, diagnosis, and treatment. J Clin Med. 2023;12:5597 https:\/\/doi.org\/10.3390\/jcm12175597.","journal-title":"J Clin Med"},{"key":"440_CR47","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3390\/biomedicines10071487","volume":"10","author":"CY Dai","year":"2022","unstructured":"Dai CY, Fang TJ, Hung WW, Tsai HJ, Tsai YC. The determinants of liver fibrosis in patients with nonalcoholic fatty liver disease and type 2 diabetes mellitus. Biomedicines. 2022;10:1487 https:\/\/doi.org\/10.3390\/biomedicines10071487.","journal-title":"Biomedicines"},{"key":"440_CR48","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1111\/liv.13221","volume":"36","author":"SK Kunutsor","year":"2016","unstructured":"Kunutsor SK. Gamma-glutamyltransferase\u2014friend or foe within?. Liver Int. 2016;36:1723\u201334. https:\/\/doi.org\/10.1111\/liv.13221.","journal-title":"Liver Int"},{"key":"440_CR49","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018;98:2133\u2013223. https:\/\/doi.org\/10.1152\/physrev.00063.2017.","journal-title":"Physiol Rev"},{"key":"440_CR50","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.freeradbiomed.2023.09.020","volume":"208","author":"A Mitri\u0107","year":"2023","unstructured":"Mitri\u0107 A, Castellano I. Targeting gamma-glutamyl transpeptidase: a pleiotropic enzyme involved in glutathione metabolism and in the control of redox homeostasis. Free Radic Biol Med. 2023;208:672\u201383. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.09.020.","journal-title":"Free Radic Biol Med"},{"key":"440_CR51","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","volume":"1830","author":"SC Lu","year":"2013","unstructured":"Lu SC. Glutathione synthesis. Biochim Biophys Acta Gen Subj. 2013;1830:3143\u20133153. https:\/\/doi.org\/10.1016\/j.bbagen.2012.09.008.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"440_CR52","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ng.2385","volume":"44","author":"RA Scott","year":"2012","unstructured":"Scott RA, Lagou V, Welch RP, Wheeler E, Montasser ME, Luan J, et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet. 2012;44:991\u20131005. https:\/\/doi.org\/10.1038\/ng.2385.","journal-title":"Nat Genet"},{"key":"440_CR53","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nature05616","volume":"445","author":"R Sladek","year":"2007","unstructured":"Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445:881\u20135. https:\/\/doi.org\/10.1038\/nature05616.","journal-title":"Nature"}],"container-title":["Nutrition & Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00440-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00440-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00440-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T23:25:50Z","timestamp":1786922750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00440-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["440"],"URL":"https:\/\/doi.org\/10.1038\/s41387-026-00440-y","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study was done following the guidelines of the 1975 Declaration of Helsinki and its revisions. The study was approved by the Institutional Ethical Committee of National Institute of Biomedical Genomics, Kalyani. Participants were recruited in the study with informed consent (Ethical clearance number: NIBMG\/2012\/1\/6, dated on January 6, 2012).","order":2,"name":"Ethics","label":"Ethical statement","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"28"}}